Details of the Drug

General Information of Drug (ID: DMP86RS)

Drug Name

CVM-1118

Synonyms

Foslinanib; UNII-2X2DNM7NGX; 5-yl dihydrogen phosphate; 2X2DNM7NGX; 1256037-60-1; 2-(3-fluorophenyl)-6-methoxy-4-oxo-1,4-dihydroquinolin-; 2-(3-Fluorophenyl)-6-methoxy-4-oxo-1,4-dihydroquinolin-5-yl dihydrogen phosphate; Foslinanib [INN]; Foslinanib [USAN]; Foslinanib (USAN/INN); Foslinanib [USAN:INN]; TRX-818 FREE ACID; SCHEMBL339272; CVM-1118 FREE ACID; CHEMBL1615993; TRX 818; WHO 10721; D11639; 4(1H)-Quinolinone, 2-(3-fluorophenyl)-6-methoxy-5-(phosphonooxy)-; 2-(3-Fluorophenyl)-4-hydroxy-6-methoxyquinolin-5-yl dihydrogen phosphate; 2054938-73-5

Indication

Disease Entry	ICD 11	Status	REF
Neuroendocrine cancer	2B72.1	Phase 2	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

Chemical Identifiers

Formula: C16H13FNO6P
Canonical SMILES: COC1=C(C2=C(C=C1)NC(=CC2=O)C3=CC(=CC=C3)F)OP(=O)(O)O
InChI: 1S/C16H13FNO6P/c1-23-14-6-5-11-15(16(14)24-25(20,21)22)13(19)8-12(18-11)9-3-2-4-10(17)7-9/h2-8H,1H3,(H,18,19)(H2,20,21,22)
InChIKey: ZDWFMAHQGDEALT-UHFFFAOYSA-N

Cross-matching ID

PubChem CID: 49840582
CAS Number: 1256037-60-1
TTD ID: DYIA63

References

1	ClinicalTrials.gov (NCT03600233) Study of CVM-1118 for Patients With Advanced Neuroendocrine Tumors. U.S. National Institutes of Health.